Back

The low expression of circulating microRNA-19a represents an additional mortality risk in stable patients with vascular disease.

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 6 - Long term prognosis in coronary artery disease Prevention ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Otto Mayer

University Hospital Pilsen, Pilsen (Czechia)

9 More presentations in this session

Presentation thumbnail
Vascular endothelial growth factor-D and mortality in suspected or known coronary heart disease patients with chronic kidney disease: a subanalysis of the ANOX study
Doctor H. Wada (Kyoto, JP)
Abstract
Presentation thumbnail
Association of atherogenic dyslipidemia with cardiovascular outcomes in patients with pre-diabetes and coronary artery disease
Doctor Y. Gao (Beijing, CN)
Presentation thumbnail
Extremely elevated lipoprotein (a) as an independent risk factor for coronary heart disease in large patient cohort
Mr M. Poudel (Bielefeld, DE)
Abstract Slides
Presentation thumbnail
Vascular endothelial growth factor-D and mortality in suspected or known coronary heart disease patients with diabetes: a subanalysis of the ANOX study
Miss M. Wada (Kyoto, JP)
Abstract
Presentation thumbnail
A systematic follow-up strategy after percutaneous coronary intervention based on patient risk profile: the prospective POST-PCI registry
Doctor M. Ferlini (Pavia, IT)
Abstract

Access the full session

Session thumbnail
Poster Session 6 - Long term prognosis in coronary artery disease

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources